FrancophonIA/ELRC3.0 huggingface dataset:
English: itching, difficulty breathing, wheezing, swelling of the face or low blood pressure), low blood sugar levels (in diabetic patients), feeling anxious, somnolence, impaired vision, fast heart beat (tachycardia), dry mouth, upset stomach, taste disturbance (dysgeusia), abnormal liver function (Japanese patients are more likely to experience this side effect), rapid swelling of the skin and mucosa which can also lead to death (angioedema also with fatal outcome), eczema (a skin disorder), redness of skin, hives (urticaria), severe drug rash, joint pain (arthralgia), pain in extremity, tendon pain, flu-like-illness, decreased haemoglobin (a blood protein), increased levels of uric acid, increased hepatic enzymes or creatine phosphokinase in the blood.
Croatian: ubrzani otkucaji srca (tahikardija), suhoća usta, nadražaj želuca, poremećaj osjeta okusa (disgeuzija), abnormalna funkcija jetre (vjerojatnost da će iskusiti ovu nuspojavu, veća je za bolesnike iz Japana), brzo oticanje kože i sluznice koji mogu dovesti do smrtnog ishoda (angioedem također sa smrtnim ishodom), ekcem (poremećaj kože), crvenilo kože, koprivnjača (urtikarija), težak osip od lijeka, bol u zglobovima (artralgija), bol u udovima, bol tetiva, simptomi nalik gripi, snižen hemoglobin (krvni protein), povišena razina mokraćne kiseline, povišeni jetreni enzimi ili kreatin fosfokinaza u krvi.
English: Magnesium stearate Croscarmellose sodium Mannitol
Croatian: 6.1 Popis pomoćnih tvari magnezijev stearat karmelozanatrij, umrežena manitol povidon pelete kalijevog hidroksida
English: Somnolence
Croatian: Vrtoglavica
English: Before considering the concomitant use of medicinal products that affect the renin-angiotensinaldosterone system, the benefit risk ratio should be evaluated.
Croatian: Prije razmatranja istodobne primjene lijekova koji utječu na sustav renin-angiotenzin-aldosteron,
English: Immune system disorders Rare:
Croatian: Poremećaji imunološkog sustava
English: Urinary tract infections, upper respiratory tract infections (e.g. sore throat, inflamed sinuses, common cold), deficiency in red blood cells (anaemia), high potassium levels, difficulty falling asleep, feeling sad (depression), fainting (syncope), feeling of spinning (vertigo), slow heart rate (bradycardia), low blood pressure (hypotension) in users treated for high blood pressure, dizziness on standing up (orthostatic hypotension), shortness of breath, cough abdominal pain, diarrhoea, discomfort in the abdomen, bloating, vomiting, itching, increased sweating, drug rash, back pain, muscle cramps, muscle pain (myalgia), kidney impairment including acute kidney failure, pain in the chest, feeling of weakness, and increased level of creatinine in the blood.
Croatian: Infekcije mokraćnih puteva, infekcije gornjih dišnih puteva (npr. grlobolja, upala sinusa, obična prehlada), nedostatak crvenih krvnih stanica (anemija), visoke razine kalija, otežano spavanje, osjećaj tuge (depresija), nesvjestica (sinkopa), osjećaj vrtnje (vrtoglavica), usporen rad srca (bradikardija), nizak krvni tlak (hipotenzija) u korisnika liječenih zbog visokog krvnog tlaka, omaglica pri ustajanju
English: NAME OF THE MEDICINAL PRODUCT Telmisartan Actavis 40 mg tablets
Croatian: NAZIV LIJEKA Telmisartan Actavis 40 mg tablete
English: NAME OF THE MEDICINAL PRODUCT Telmisartan Actavis 40 mg tablets telmisartan
Croatian: NAZIV LIJEKA Telmisartan Actavis 40 mg tablete telmisartan
English: NAME OF THE MEDICINAL PRODUCT Telmisartan Actavis 80 mg tablets telmisartan
Croatian: NAZIV LIJEKA Telmisartan Actavis 80 mg tablete telmisartan
English: NAME OF THE MEDICINAL PRODUCT Telmisartan Actavis 20 mg tablets
Croatian: NAZIV LIJEKA Telmisartan Actavis 20 mg tablete
English: PHARMACEUTICAL FORM Tablet
Croatian: 14. NAČIN IZDAVANJA LIJEKA
English: Blood and the lymphatic system disorders Uncommon:
Croatian: Poremećaji krvi i limfnog sustava
English: NAME OF THE MEDICINAL PRODUCT Telmisartan Actavis 20 mg tablets telmisartan
Croatian: NAZIV LIJEKA Telmisartan Actavis 20 mg tablete telmisartan
English: NAME OF THE MEDICINAL PRODUCT Telmisartan Actavis 80 mg tablets
Croatian: NAZIV LIJEKA Telmisartan Actavis 80 mg tablete
English: 6.6 Special precautions for disposal and other handling
Croatian: 6.6 Posebne mjere za zbrinjavanje i druga rukovanja lijekom Nema posebnih zahtjeva.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 80 mg telmisartan.
Croatian: KVALITATIVNI I KVANTITATIVNI SASTAV Jedna tableta sadrži 80 mg telmisartana.
English: Telmisartan was found to be similarly effective to ramipril in the pre-specified secondary endpoint of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke [0.99 (97.5% CI 0.901.08), p (non-inferiority) = 0.0004], the primary endpoint in the reference study HOPE (The Heart Outcomes Prevention Evaluation Study), which had investigated the effect of ramipril vs. placebo.
Croatian: (97,5% CI 0,90 - 1,08), p (neinferiornost) = 0,0004], u primarnom ishodu referentnog ispitivanja HOPE (The Heart Outcomes
English: MARKETING AUTHORISATION NUMBER(S) EU/1/10/639/029 (30 tablets container) EU/1/10/639/030 (250 tablets container)
Croatian: 12. BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/10/639/029 (spremnik s 30 tableta) EU/1/10/639/030 (spremnik s 250 tableta)
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 40 mg telmisartan.
Croatian: KVALITATIVNI I KVANTITATIVNI SASTAV Jedna tableta sadrži 40 mg telmisartana.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 20 mg telmisartan.
Croatian: KVALITATIVNI I KVANTITATIVNI SASTAV Jedna tableta sadrži 20 mg telmisartana.
English: Most cases of hepatic function abnormal / liver disorder from post-marketing experience occurred in patients in Japan, who are more likely to experience these adverse reactions.
Croatian: abnormalna funkcija jetre (vjerojatnost da će iskusiti ovu nuspojavu, veća je za bolesnike iz Japana),
English: MARKETING AUTHORISATION NUMBER(S) EU/1/10/639/019 (30 tablets container) EU/1/10/639/020 (250 tablets container)
Croatian: 12. BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/10/639/019 (spremnik s 30 tableta) EU/1/10/639/020 (spremnik s 250 tableta)
English: MARKETING AUTHORISATION NUMBER(S) EU/1/10/639/009 (30 tablets container) EU/1/10/639/010 (250 tablets container)
Croatian: 12. BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/10/639/009 (spremnik s 30 tableta) EU/1/10/639/010 (spremnik s 250 tableta)
English: Tachycardia
Croatian: Bradikardija Tahikardija
English: Take Telmisartan Actavis every day for as long as your doctor prescribes it in order to keep your blood pressure controlled.
Croatian: Ako prestanete uzimati Telmisartan Actavis Kako biste držali svoj tlak pod kontrolom, uzimajte Telmisartan Actavis svaki dan toliko dugo koliko
English: EU/1/10/639/001 (14 tablets blister) EU/1/10/639/002 (28 tablets blister) EU/1/10/639/003 (30 tablets blister) EU/1/10/639/004 (56 tablets blister) EU/1/10/639/005 (84 tablets blister) EU/1/10/639/006 (90 tablets blister) EU/1/10/639/007 (98 tablets blister) EU/1/10/639/008 (100 tablets blister)
Croatian: EU/1/10/639/005 (blister s 84 tablete) EU/1/10/639/006 (blister s 90 tableta) EU/1/10/639/007 (blister s 98 tableta) EU/1/10/639/008 (blister sa 100 tableta)
English: Common side effects (may affect up to 1 in 10 people): Low blood pressure (hypotension) in users treated for reduction of cardiovascular events.
Croatian: Nizak krvni tlak (hipotenzija) u bolesnika liječenih zbog smanjivanja kardiovaskularnih događaja.
English: EU/1/10/639/011 (14 tablets blister) EU/1/10/639/012 (28 tablets blister) EU/1/10/639/013 (30 tablets blister) EU/1/10/639/014 (56 tablets blister) EU/1/10/639/015 (84 tablets blister) EU/1/10/639/016 (90 tablets blister) EU/1/10/639/017 (98 tablets blister) EU/1/10/639/018 (100 tablets blister)
Croatian: EU/1/10/639/015 (blister s 84 tablete) EU/1/10/639/016 (blister s 90 tableta) EU/1/10/639/017 (blister s 98 tableta) EU/1/10/639/018 (blister sa 100 tableta)
English: EU/1/10/639/021 (14 tablets blister) EU/1/10/639/022 (28 tablets blister) EU/1/10/639/023 (30 tablets blister) EU/1/10/639/024 (56 tablets blister) EU/1/10/639/025 (84 tablets blister) EU/1/10/639/026 (90 tablets blister) EU/1/10/639/027 (98 tablets blister) EU/1/10/639/028 (100 tablets blister)
Croatian: EU/1/10/639/025 (blister s 84 tablete) EU/1/10/639/026 (blister s 90 tableta) EU/1/10/639/027 (blister s 98 tableta) EU/1/10/639/028 (blister sa 100 tableta)
English: Cardiac disorders Uncommon:
Croatian: Kardiovaskularna prevencija ONTARGET ispitivanje (eng.
English: Renal impairment including acute renal failure General disorders and administration site conditions Uncommon: Rare:
Croatian: Opći poremećaji i reakcije na mjestu primjene Manje često:
English: Teл.
Croatian: (tahikardija).
English: Back pain (e.g. sciatica), muscle spasms, myalgia Arthralgia, pain in extremity, tendor pain (tendinitis like symptoms)
Croatian: Artralgija, bol u ekstremitetima, bol tetiva (simptomi poput tendinitisa)
English: EU/1/10/639/001 (14 tablets blister) EU/1/10/639/002 (28 tablets blister) EU/1/10/639/003 (30 tablets blister) EU/1/10/639/004 (56 tablets blister) EU/1/10/639/005 (84 tablets blister) EU/1/10/639/006 (90 tablets blister) EU/1/10/639/007 (98 tablets blister) EU/1/10/639/008 (100 tablets blister) EU/1/10/639/009 (30 tablets container) EU/1/10/639/010 (250 tablets container)
Croatian: EU/1/10/639/001 (blister s 14 tableta) EU/1/10/639/002 (blister s 28 tableta) EU/1/10/639/003 (blister s 30 tableta) EU/1/10/639/004 (blister s 56 tableta)
English: Inventedname Strength Pharmaceutical Form
Croatian: (Zaštićeno) ime Jačina Farmaceutski oblik
English: EU number
Croatian: Brojevi (EU) odobrenja za stavljanje lijeka u promet
English: If you need more information about your animal's medical condition or treatment, contact your veterinarian.
Croatian: Ako trebate više informacija o zdravstvenom stanju ili liječenje svoje životinje, obratite se veterinaru.
English: Vaccines work by ‘teaching' the immune system (the body's natural defences) how to defend itself against a disease.
Croatian: Cjepiva djeluju „učeći” imunosni sustav (prirodna obrana tijela) kako se obraniti od bolesti.
English: They included young and adult cats of various breeds, but not young kittens.
Croatian: Ispitivanja su obuhvatila mlade i odrasle mačke različitih pasmina, ali ne i mlade mačiće.
English: This is a summary of the European public assessment report.
Croatian: Ovo je sažetak europskoga javnog izvješća o ocjeni dokumentacije.
English: The antibodies will help to protect against the diseases caused by these viruses.
Croatian: Protutijela pomažu u zaštiti od bolesti koje uzrokuju ti virusi.
English: The first injection should be given in kittens aged at least eight weeks, with a second injection three to four weeks later.
Croatian: Prvu injekciju treba dati mačićima u dobi od najmanje osam tjedana, a drugu injekciju tri do četiri tjedna kasnije.
English: The cat should be revaccinated for all components one year after the first vaccination course, then every three years.
Croatian: Potrebno je provesti revakcinaciju mačke za sve komponente godinu dana nakon prvog cijepljenja, a zatim svake tri godine.
English: When exposed to any of these viruses later in life, the cat will either not become infected or have a much less serious infection.
Croatian: Ako u budućnosti bude izložena nekom od tih virusa, mačka se neće zaraziti ili će imati mnogo blažu infekciju.
English: Information on the prescription status of this product may be found on the label/outer package.
Croatian: Informacije o tome je li za ovaj proizvod potreban recept možete naći na etiketi/vanjskom pakiranju.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Purevax RC on 23 February 2005.
Croatian: Europska komisija izdala je odobrenje za stavljanje u promet koje je za VMP Purevax RC na snazi u Europskoj uniji od 23. veljače 2005.
English: If the kitten has high levels of antibodies received from the mother in the womb and in the milk, the first vaccination should be delayed until 12 weeks of age.
Croatian: Ako mačić ima visoke razine majčinih protutijela prenesenih u maternici i mlijekom, prvo cijepljenje trebalo bi odgoditi do dobi od 12 tjedana.
English: Purevax RC should not be used in pregnant cats.
Croatian: Purevax RC ne smije se primjenjivati u gravidnih mačaka.
English: The main measure of effectiveness was the level of antibodies in the blood against the viruses in the vaccine.
Croatian: Glavna mjera djelotvornosti bila je razina protutijela u krvi na viruse iz cjepiva.
English: Occasionally, cats will develop temporary apathy (loss of interest in surroundings) and anorexia (loss of appetite), as well as hyperthermia (elevated body temperature) lasting for one or two days.
Croatian: U mačaka se povremeno može javiti privremena apatija (gubitak interesa za okolinu) i anoreksija (gubitak apetita), kao i hipertermija (povišena tjelesna temperatura) koja traje jedan ili dva dana.
English: The vaccine helps to reduce the symptoms of the diseases and also helps to reduce viral excretion in case of calicivirus infection for one year after vaccination.
Croatian: Cjepivo pomaže u ublažavanju simptoma bolesti, kao i u smanjenju ekskrecije virusa u slučaju infekcije kalicivirusom tijekom jedne godine nakon cijepljenja.
English: There may be a local reaction at the injection site, with slight pain on touching, itching or oedema (swelling), which disappears within one or two weeks.
Croatian: Može se pojaviti i lokalna reakcija na mjestu injekcije u obliku lagane boli na dodir, svrbeža ili edema (otok), koja nestaje unutar jednog ili dva tjedna.
English: When a cat is given the vaccine, the immune system recognises the weakened or killed viruses as ‘foreign' and makes antibodies against them.
Croatian: Kada mačka primi cjepivo, imunosni sustav prepoznaje oslabljene ili umrtvljene viruse kao „strana tijela” te protiv njih proizvodi protutijela.
English: The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Purevax RC exceed the risks for the approved indications and recommended that Purevax RC be given a marketing authorisation.
Croatian: Odbor za veterinarsko-medicinske proizvode (CVMP) zaključio je da koristi od VMP-a Purevax RC nadmašuju rizike za odobrene indikacije te je preporučio davanje odobrenja za stavljanje VMP-a Purevax RC u promet.
English: Purevax RC is used to vaccinate cats from the age of 8 weeks against:
Croatian: Purevax RC koristi se za cijepljenje mačaka starijih od osam tjedana protiv:
English: In the future, the immune system will be able to produce antibodies more quickly when it is again exposed to the viruses.
Croatian: Nakon cijepljenja imunosni sustav može brže proizvoditi protutijela ako u budućnosti bude izložen stvarnim virusima.
English: • inactivated (killed) calicivirosis antigens (FCV 431 and G1 strains).
Croatian: • inaktivirane (umrtvljene) antigene kalicivirusa (sojeve FCV 431 i G1).
English: In case of accidental self-injection medical advice should be sought immediately and the package leaflet or the label shown to the doctor.
Croatian: U slučaju nehotičnog samoinjektiranja treba odmah potražiti liječnički savjet te pokazati uputu o proizvodu ili etiketu.
English: Purevax RC is a veterinary vaccine that contains:
Croatian: Purevax RC je veterinarsko cjepivo koje sadrži:
English: The benefit-risk balance may be found in the scientific discussion module of this EPAR.
Croatian: Omjer koristi i rizika možete pronaći u modulu znanstvene rasprave ovog EPAR-a.
English: The effectiveness of Purevax RC has been studied in several trials in laboratory conditions where cats were vaccinated and infected with herpesvirus and calicivirus.
Croatian: Djelotvornost VMP-a Purevax RC ispitivana je u nekoliko ispitivanja u laboratorijskim uvjetima, u okviru kojih su mačke cijepljene i potom zaražene herpesvirusom i kalicivirusom.
English: In laboratory conditions Purevax RC was demonstrated to provide protection against the diseases listed above.
Croatian: U laboratorijskim uvjetima dokazano je da VMP Purevax RC pruža zaštitu od prethodno navedenih bolesti.
English: Purevax RC is available as a lyophilisate (freeze-dried pellet) and solvent that are made up into a suspension for injection.
Croatian: Purevax RC dostupan je kao liofilizat (smrzavanjem osušen pelet) i otapalo od kojih se priprema suspenzija za injekciju.
English: Purevax RC contains small amounts of weakened or killed viruses that cause feline rhinotracheitis and calicivirosis.
Croatian: Purevax RC sadrži male količine oslabljenih ili umrtvljenih virusa koji uzrokuju rinotraheitis i kalicivirozu mačaka.
English: In the field, the studies of Purevax RC looked at the basic vaccination schedule (2 injections 3-4 weeks apart) and at the booster vaccination.
Croatian: U ispitivanjima VMP-a Purevax RC na terenu razmatrao se osnovni raspored cijepljenja (dvije injekcije u razmaku od tri do četiri tjedna) te docjepljivanje.
English: • attenuated (weakened) feline rhinotracheitis herpesvirus (FHV F2 strain),
Croatian: • atenuirani (oslabljeni) herpesvirus rinotraheitisa mačaka (soj FHV F2),
English: Purevax RC is a vaccine.
Croatian: Purevax RC je cjepivo.
English: • feline calicivirosis (a flu-like illness with inflammation of the mouth caused by a calicivirus).
Croatian: • kaliciviroze mačaka (bolest nalik na gripu s upalom usta uzrokovana kalicivirusom).
English: Feline viral rhinotracheitis (live attenuated) and feline calicivirosis (inactivated) vaccine
Croatian: Cjepivo protiv virusnog rinotraheitisa (živo atenuirano) i kaliciviroze mačaka (inaktivirano)
English: What is the risk associated with Purevax RC?
Croatian: Koji su rizici povezani s VMP-om Purevax RC?
English: For a full list of the side-effects reported with Purevax RC, see the package leaflet.
Croatian: Potpuni popis svih nuspojava zabilježenih pri primjeni VMP-a Purevax RC potražite u uputi o VMP-u.
English: Why has Purevax RC been approved?
Croatian: Zašto je Purevax RC odobren?
English: In the field study of basic vaccination there was an increase in antibodies against feline rhinotracheitis herpesvirus and calicivirus infection.
Croatian: U terenskom ispitivanju osnovnog cijepljenja zabilježen je porast protutijela na herpesvirus rinotraheitisa i kalicivirus u mačaka.
English: What is Purevax RC?
Croatian: Što je Purevax RC?
English: Other information about Purevax RC:
Croatian: Ostale informacije o VMP-u Purevax RC
English: What is Purevax RC used for?
Croatian: Za što se Purevax RC koristi?
English: • feline viral rhinotracheitis (a flu-like illness caused by a herpesvirus),
Croatian: • virusnog rinotraheitisa mačaka (bolest nalik na gripu uzrokovana herpesvirusom),
English: What benefit has Purevax RC shown during the studies?
Croatian: Koje su koristi VMP-a Purevax RC utvrđene u ispitivanjima?
English: How does Purevax RC work?
Croatian: Kako djeluje Purevax RC?
English: In the study looking at booster vaccination, antibody levels against rhinotracheitis herpesvirus and calicivirus infection remained stable at a high level or increased slightly.
Croatian: U ispitivanju koje je promatralo docjepljivanje, zabilježena je stabilna visoka razina ili blagi porast protutijela na herpesvirus rinotraheitisa i kalicivirus.
English: How has Purevax RC been studied?
Croatian: Kako je VMP Purevax RC ispitivan?
English: 15 micrograms HA** per 0.5 ml dose
Croatian: 15 mikrograma HA** u dozama od 0,5 ml
English: Influenza virus surface antigens (haemagglutinin and neuraminidase)*, inactivated, of the following strains: A/California/7/2009 (H1N1)pdm09- like strain (A/Brisbane/10/2010, wild type)
Croatian: 1 Površinski antigeni virusa gripe (hemaglutinin i neuraminidaza)*, inaktivirani, sljedećih sojeva: soj sličan A/California/7/2009 (H1N1)pdm09 - (divlji tip A/Brisbane/10/2010)
English: A/Switzerland/9715293/2013 (H3N2) - like strain (A/South Australia/55/2014, wild type)
Croatian: soj sličan A/Switzerland/9715293/2013 (H3N2) - (divlji tip A/South Australia/55/2014)
English: B/Phuket/3073/2013 - like strain (B/Utah/9/2014, wild type)
Croatian: soj sličan B/Phuket/3073/2013 - (divlji tip B/Utah/9/2014)
English: * propagated in Madin Darby Canine Kidney (MDCK) cells ** haemagglutinin
Croatian: * umnoženo u psećim renalnim stanicama Madin Darby (MDCK) ** hemaglutinin k i
English: Strength Pharmaceutical Form Route of Administration
Croatian: Doza Farmaceutski oblik Put primjene Unutarnje pakovanje Sastav (koncentracija)
English: 2 x 10 pre-filled syringes (Luer Cone) + 20 needles
Croatian: 2 x 10 štrcaljka s uloškom (Luer nastavak) + 20 igla
English: 2 x 10 pre-filled syringes (Luer Lock)
Croatian: 2 x 10 štrcaljka s uloškom (Luer Lock)
English: 2 x 10 pre-filled syringes (Luer Cone)
Croatian: 2 x 10 štrcaljka s uloškom (Luer nastavak)
English: EU numbers
Croatian: Sastav
English: Further information on Rhokiinsa can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/rhokiinsa
Croatian: Više informacija o lijeku Rhokiinsa dostupno je na internetskim stranicama Agencije: ema.europa.eu/medicines/human/EPAR/rhokiinsa.
English: It is available as an eye-drop solution (200 microgram/ml) and the dose is one drop in the affected eye once a day, in the evening.
Croatian: Dostupan je kao otopina kapi za oči (200 mikrograma/ml), a doza je jedna kap u oboljelo oko jednom dnevno, navečer.
English: What is Rhokiinsa and what is it used for?
Croatian: Što je Rhokiinsa i za što se koristi?
English: What measures are being taken to ensure the safe and effective use of Rhokiinsa?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Rhokiinsa?
English: The European Medicines Agency therefore decided that Rhokiinsa's benefits are greater than its risks and it can be authorised for use in the EU.
Croatian: Europska agencija za lijekove stoga je zaključila da koristi od lijeka Rhokiinsa nadmašuju s njim povezane rizike te da lijek može biti odobren za primjenu u EU-u.
English: Side effects reported with Rhokiinsa are carefully evaluated and any necessary action taken to protect patients.
Croatian: Nuspojave prijavljene za lijek Rhokiinsa pažljivo se procjenjuju i poduzimaju se potrebne mjere za zaštitu bolesnika.
English: In patients with moderately high eye pressure (up to 25 mmHg), Rhokiinsa was as effective as timolol (another medicine), lowering the pressure by around 3.9 mmHg to 4.7 mmHg, compared with reductions of 3.8 mmHg to 5.2 mmHg for patients using timolol.
Croatian: U bolesnika s umjereno visokim očnim tlakom (do 25 mmHg), lijek Rhokiinsa bio je jednako djelotvoran kao i timolol (drugi lijek) te je snizio tlak za oko 3,9 mmHg, tj. na 4,7 mmHg, u usporedbi sa smanjenjem od 3,8 mmHg, tj. na 5,2 mmHg u bolesnika koji su uzimali timolol.
English: However, when these results were combined with results from other studies, decreases in eye pressure with Rhokiinsa were larger than those seen in the main study only.
Croatian: Međutim, kada se ti rezultati kombiniraju s rezultatima iz drugih ispitivanja, smanjenja vrijednosti očnog tlaka s lijekom Rhokiinsa bila su veća od onih utvrđenih samo u glavnom ispitivanju.
English: When pressure in the eye is raised, it can cause damage to the retina (the light-sensitive membrane at the back of the eye) and to the optic nerve that sends signals from the eye to the brain.
Croatian: Kada je očni tlak povišen, može doći do oštećenja retine (opne osjetljive na svjetlo koja se nalazi u stražnjem dijelu oka) i optičkog živca koji odašilje signale iz oka u mozak.
English: However, side effects on the eye were more frequent than those of timolol, and this may lead people to stop treatment.
Croatian: Međutim, nuspojave na oku bile su učestalije od nuspojava uzrokovanih timololom, što može navesti ljude da prestanu s liječenjem.
English: The safety of Rhokiinsa will be further investigated in a study.
Croatian: Sigurnost lijeka Rhokiinsa nastavit će se istraživati u ispitivanju.